<DOC>
	<DOCNO>NCT00604006</DOCNO>
	<brief_summary>Individuals part investigator Screen-HF study ( NCT00400257 ) whose BNP level top quintile offer participation study . Participants randomise receive either spironolactone placebo three year . Participants monitor indication heart failure . It anticipate medication reduce development heart failure group .</brief_summary>
	<brief_title>SCREEN-HFI ( SCReening Evaluation Evolution New Heart Failure Intervention Study )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>1 . Was recruit SCREENHF 2 . Has provide inform consent 1 . Uncorrected hyperkalaemia 2. eGFR &lt; 30 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Prevention heart failure individual high risk</keyword>
</DOC>